Clinical Trial Update: Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for masitinib in locally advanced/metastatic gastrointestinal stromal tumours (GIST) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastro-intestinal Stromal Tumours

Drugs mentioned

• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Gastro-intestinal Stromal Tumours | Phase 2 | Status: COMPLETED